What does the phrase “an app store for personal genomics” actually mean? We decided to find out more about this new, personalised frontier
Thanks to the growth of genomic technology, predicting an individual’s health costs purely based around their genetic ‘score’ could well be a reality
In the latest issue of FLG magazine we met a biochemist at the intersection of metabolomics and genomics: Greg Michelotti of Metabolon
We’ve all been told that next generation sequencing is revolutionising healthcare. But how is it actually being applied, today?
Heather Norwood, executive director of the International FOXG1 Foundation introduces us to the human story behind their vital work
Autism presents a unique challenge to medical geneticists. Heading the charge to understand the genetics is Dr Steve Scherer
Frances Addison looks at the 14 day rule for embryos, and what it means for ‘synthetic human entities with embryo-like features’
Qatar is bringing precision medicine to their population and setting a global example
We sat down with Dr Cem Albayrak of Koç University to discuss a particularly exciting technology called droplet digital PCR
A very special drug, whose development was guided by artificial intelligence to treat a rare form of brain cancer has moved into a phase I/II clinical trial
We caught up with Aspera’s Michael Ortega to learn how their novel transfer system is helping to connect researchers across the world.
Iain Macauley, Technical Development Group Leader at the Earlham Institute, takes us through a typical day in his life as a single cell scientist
We caught up with Raw Science’s Founder Keri Kukral to find out what her motivations were and how she views the current world of STEM
John Ryals, PhD, President and CEO of Metabolon, explains how metabolites can be a powerful precision medicine ally, for both researchers and clinicians
Toby Hannam from Incisive Health reflects on a Festival of Genomics notable for the absence of a leading politician